The short answer
The inspected clinical evidence does not establish that L-glutamine supplements increase seizures with valproate. Discuss use with your prescriber; there is no proven separation schedule, and lack of evidence does not prove safety.
What this answer covers
Oral L-glutamine supplements with valproate. Endogenous blood or brain glutamine, glutamate, glutamine synthetase disorders and cell-culture glutamine are not oral supplementation exposures.
- Supplement or preparation
- L-Glutamine
- Medication ingredient
- valproate
What the available study measured
A report of seven adults with valproate-related encephalopathy measured glutamine in blood or cerebrospinal fluid. Some levels were elevated. The study did not give participants a glutamine supplement, so it cannot show that supplemental glutamine causes seizures with valproate.
Do not confuse different exposures
Glutamine already present in the body is different from an oral supplement dose. Glutamate is also a different substance. A change in a laboratory measurement during illness cannot establish the effect of a supplement, its safe dose or whether it changes valproate effectiveness.
Discuss the reason for using it
Before adding L-glutamine, discuss the purpose, exact product and dose with your epilepsy or prescribing team. The inspected sources establish neither a routine prohibition nor a proven hours-apart schedule for this combination. Keep taking valproate as prescribed while arranging advice.
Respond to new symptoms
Seek prompt medical assessment for unexplained confusion, marked sleepiness, vomiting or worsening seizure control. Valproate itself can cause high ammonia and other serious adverse effects. Tell the clinician about all supplements so the cause can be evaluated without assuming glutamine is responsible.
Evidence and practical considerations
Side effects & toxicity
The inspected evidence does not establish that supplemental L-glutamine increases seizures with valproate or that a specific separation interval prevents an interaction.
- Exact scope
- Oral L-glutamine supplements with valproate. Endogenous blood or brain glutamine, glutamate, glutamine synthetase disorders and cell-culture glutamine are not oral supplementation exposures. with Valproate RxCUI 40254 IN. NLM identifies valproic acid and sodium valproate as related precise ingredients; oral valproic acid dissociates to valproate. This active-moiety bridge does not equate release kinetics, all salts, doses or routes.
- Medication form and route
- Oral
What remains uncertain
- The relevant original series measured endogenous glutamine during encephalopathy, not supplement exposure. No qualifying clinical co-use trial was identified; this does not prove safety.
Factors that may matter: Exact preparation and route; Age and clinical indication; Baseline nutritional status; Other treatments.
Read the supporting source summaries
Source 1: Current U.S. prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients receiving oral valproic acid.
Recommends folic acid before conception and during pregnancy for women of childbearing potential. Protection against valproate-associated neural tube defects or reduced IQ is unknown. Warns of hyperammonemia and abrupt discontinuation. States no extent-of-absorption effect in the specified antacid study.
How this applies: Exact active-moiety safety and formulation-specific context. Valproate RxCUI 40254 IN. NLM identifies valproic acid and sodium valproate as related precise ingredients; oral valproic acid dissociates to valproate. This active-moiety bridge does not equate release kinetics, all salts, doses or routes.
Not proof of universal nutrient deficiency or of an interaction with each supplement. The antacid summary differs from the original 1982 abstract; that difference is retained.
Source 2: Original clinical research
ebi.ac.uk · Source check Sep 10, 2026
Population: Seven adults with valproate-related hyperammonemic encephalopathy.
Glutamine was elevated in four of five tested patients. Symptoms resolved after valproate reduction or discontinuation; EEGs in six supported encephalopathy and excluded nonconvulsive status.
How this applies: Medication-only biomarker evidence, explicitly excluded as direct supplement interaction evidence.
Measures endogenous glutamine during an adverse drug effect. Does not test supplemental L-glutamine, prove that it causes seizures or establish a separation interval.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Sources checked and article drafted. | |
| Research summary published |
Article revision: 9ab7f9f62017eaba
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.